Responses
Systematic review
Erythropoietin treatment in patients with chronic heart failure: a meta-analysis
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015Risk of Bias in Meta-analysis on Erythropoietin-stimulating Agents in Heart FailureShow More
To the editor: We are delighted by the encouraging results reported in van der Meer et al.'s meta-analysis [1] regarding lower hospitalization rates of erythropoiesis-stimulating agents (ESAs) in heart failure (HF). However, the possibility of bias in the studies included in the meta- analysis might be greater than assessed by the authors.
First, the methodological quality of the reviewed studies was limited accor...
Conflict of Interest:
None declared.